141281-95-0

Basic information

• Product Name: ramatroban
• Synonyms: 9H-Carbazole-9-propanoic acid, 3-[[(4-fluorophenyl)sulfonyl]amino]-1,2,3,4-tetrahydro- (9CI);3- (4-Fluorophenyl) sulfonyl aMino -1,2,3,4-tetrahydro-9H -carbazole-9-propanoic acid
• CAS NO: 141281-95-0
• Molecular Formula: C21H21 F N2 O4 S
• Molecular Weight: 416.47
• Mol File: 141281-95-0.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• CAS DataBase Reference: ramatroban(CAS DataBase Reference)
• NIST Chemistry Reference: ramatroban(141281-95-0)
• EPA Substance Registry System: ramatroban(141281-95-0)

Safety Data

• Hazardous Substances Data: 141281-95-0(Hazardous Substances Data)

Usage

Description

Ramatroban is a pharmaceutical drug that is primarily used in Japan for treating allergic rhinitis. It functions by blocking the actions of thromboxane A2, a lipid molecule involved in blood clotting and inflammation, and prostaglandin D2, a hormone-like substance associated with allergies. This dual action makes Ramatroban effective at inhibiting platelet aggregation, decreasing bronchial constriction, and reducing nasal symptoms associated with allergies.

Uses

Used in Pharmaceutical Industry:
Ramatroban is used as an anti-allergic medication for the treatment of allergic rhinitis. It works by blocking the actions of thromboxane A2 and prostaglandin D2, which are involved in blood clotting, inflammation, and allergic reactions, respectively. This helps in reducing the symptoms of allergic rhinitis, such as nasal congestion and sneezing.
Used in Medical Treatments:
Ramatroban is used as a therapeutic agent for managing the symptoms of allergic rhinitis. By inhibiting platelet aggregation and decreasing bronchial constriction, it provides relief from the discomfort and inconvenience caused by this condition.
Used in Oral Administration:
Ramatroban is used as an orally administered drug for the treatment of allergic rhinitis. The oral administration method allows for easy and convenient consumption, making it a preferred choice for patients suffering from this condition.